57 results on '"IPSS"'
Search Results
2. Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation
3. Does Significant Weight Loss After Bariatric Surgery Affect Sexual Function and Urinary Symptoms? An Iranian Study
4. Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database
5. Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes
6. Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm
7. Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
8. Visual Analogue Score for Urinary Symptoms—VASUS, validation of a visual scale for lower urinary tract symptoms (LUTS) in an African country
9. Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Lower Urinary Tract Symptoms in Males
10. Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study
11. Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States
12. ‘En Bloc’ HoLEP with early apical release in men with benign prostatic hyperplasia
13. Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
14. Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms’ scenario
15. Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia
16. Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
17. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study
18. Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances
19. Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study
20. Does the Intensity of Cutting Power Affect Postoperative Symptoms During Transurethral Resection with a Monopolar System?
21. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study
22. Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study
23. Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy
24. Is prolactin measurement of value during inferior petrosal sinus sampling in patients with adrenocorticotropic hormone-dependent Cushing’s Syndrome?
25. There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
26. Changes in S-PSA after transurethral resection of prostate and its correlation to postoperative outcome
27. PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH
28. Myelodysplasia: New Approaches
29. The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study
30. Characteristics of MDS patients seen at private practices differ significantly from those treated at university hospitals in Germany
31. Prognostication in Primary Myelofibrosis
32. Effects of pulsed electromagnetic fields on benign prostate hyperplasia
33. Management of Lower-Risk Myelodysplastic Syndromes:The Art and Evidence
34. The Search for Better Prognostic Models in Myelodysplastic Syndromes
35. Laparoscopic versus laparotomic radical en bloc hysterectomy and colorectal resection for endometriosis
36. Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer
37. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity
38. Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
39. Prospective analysis of clinical and cytogenetic features of 435 cases of MDS diagnosed using the WHO (2001) classification: a prognostic scoring system for predicting survival in RCMD
40. The value of appropriate assessment prior to specialist referral in men with prostatic symptoms
41. Analysis of WHO-based Prognostic Scoring System (WPSS) of myelody-splastic syndrome and its comparison with international prognostic scoring system (IPSS) in 100 Chinese patients
42. Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan
43. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
44. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes
45. Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study
46. Patient’s Quality of Life and Coping Style Influence General Practitioner’s Management in Men with Lower Urinary Tract Symptoms: The Krimpen Study
47. Serial changes of international prostate symptom score following I-125 prostate brachytherapy
48. High-dose-rate-Brachytherapie beim Risikoprostatakarzinom
49. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
50. Terazosin in the Treatment of Premature Ejaculation: A Short-term Follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.